Study of Wrist Fusions With the Medartis Aptus Arthrodesis Plate (STIF)

January 4, 2024 updated by: Waldfriede Hospital

Investigation of the Functional Status After Wrist Arthrodesis (Medartis Aptus Model) in Patients With Rheumatoid Arthritis Compared to Patients With Post-traumatic Wrist Destruction

The primary working hypothesis of this study is whether wrist arthrodesis leads to an improvement in functional status in both rheumatoid arthritis and post-traumatic osteoarthritis. Functional status will be measured by Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire no earlier than 1 year after surgery.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

73

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals who have either suffered wrist destruction due to rheumatiod arthritis inflammation, or individuals who have received wrist fusion due to post-traumatic osteoarthritis.

Description

Inclusion Criteria:

  • Age 18-90
  • Wrist fusion took place between 2014 and 2022 using Aptus 2.5 TriLock Total Wrist Fusion Plate, Medartis at Hospital Waldfriede
  • rheumatoid Arthritis
  • post-traumatic osteoarthritis patterns: 1. scapholunate advanced collapse (SLAC) or 2. scaphoid nonunion advanced collapse (SNAC)

Exclusion Criteria:

  • post surgery bone fracture of the same limb
  • Pregnancy, lactation
  • active malignant tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Rheumatoid Arthritis wrist destruction
Patients with rheumatoid arthritis who received an APTUS wrist fusion system after 01.01.2014
Observation after implantation of Medartis Aptus Wrist Arthrodesis Plate
Osteoarthritis wrist destruction
Patients with post-traumatic wrist osteoarthritis who received an APTUS wrist fusion system after 01.01.2014
Observation after implantation of Medartis Aptus Wrist Arthrodesis Plate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disabilities of the Arm, Shoulder and Hand questionnaire (DASH)
Time Frame: all patients who underwent surgery between 2014 to 2022
Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5)
all patients who underwent surgery between 2014 to 2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: all patients who underwent surgery between 2014 to 2022
Number of Participants with impaired wound healing, Re-surgery, Material loosening
all patients who underwent surgery between 2014 to 2022
Function
Time Frame: all patients who underwent surgery between 2014 to 2022
Grip force of the hand in Kg
all patients who underwent surgery between 2014 to 2022
Functional assessment: Goniometry
Time Frame: all patients who underwent surgery between 2014 to 2022
ROM of each joint of the hand with a goniometer.
all patients who underwent surgery between 2014 to 2022
Visual analogue scale (VAS) Pain
Time Frame: all patients who underwent surgery between 2014 to 2022
From 0mm (no pain) to 100mm (maximum pain imaginable)
all patients who underwent surgery between 2014 to 2022
Short-Form 36 (SF-36)
Time Frame: all patients who underwent surgery between 2014 to 2022
Scored review of health questionnaire SF36: minimum value = 0 ; maximum value = 100
all patients who underwent surgery between 2014 to 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Markus Bock, MD, Hospital Waldfriede, Argentinische Allee 40, 14163 Berlin
  • Study Chair: Lautenbach Martin, MD, Hospital Waldfriede, Argentinische Allee 40, 14163 Berlin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2023

Primary Completion (Actual)

January 4, 2024

Study Completion (Actual)

January 4, 2024

Study Registration Dates

First Submitted

May 2, 2023

First Submitted That Met QC Criteria

May 23, 2023

First Posted (Actual)

May 25, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wrist Arthritis

Clinical Trials on Total wrist fusion

3
Subscribe